We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 1206

Topic: Disease/vaccine specific information

Page 54 of 61

This website details the work of STOPENTERICS, a consortium of independent organizations around the world dedicated to accelerating the development of Shigella and enterotoxigenic Escherichia coli vaccines for children in the developing world.


Strategic Advisory Group of Experts Japanese Encephalitis Recommendations

This issue of the Weekly Epidemiological Record includes recommendations on Japanese encephalitis control through immunization, as provided at the April 2006 Strategic Advisory Group of Experts meeting.

Author: World Health Organization

Publication date: 2006

Strategic Advisory Group of Experts Recommendations: Rotavirus Vaccination

This issue of the Weekly Epidemiological Record reports on the World Health Organization's Strategic Advisory Group of Experts' recommendation for inclusion of rotavirus vaccines in all national immunization programs. The new …

Author: World Health Organization

Publication date: 2009

Strategic Advisory Group of Experts Recommendations: Rotavirus Vaccines

This issue of the Weekly Epidemiological Record provides recommendations and commentary from a SAGE meeting that recognized the safety of rotavirus vaccines among the populations studied and called for clinical trials to determine the vaccines' …

Author: World Health Organization

Publication date: 2006

Strategic Planning and Situation Assessment for Cervical Cancer Prevention: Practical Experience from PATH

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Author: PATH

Publication date: 2011

Strategic Priorities for Respiratory Syncytial Virus (RSV) Vaccine Development

This review article, published in Vaccine, examines the clinical and epidemiological features of respiratory syncytial virus (RSV), highlights challenges and opportunities for RSV vaccine development, and identifies priority areas for future …

Author: Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS

Publication date: 2013

Strategies for HPV Vaccination in the Developing World

Developing strategies to effectively reach adolescent girls with HPV vaccines—a population not typically the focus of public health programs—is essential to achieving high coverage rates and reducing the cervical cancer burden. This issue brief …

Author: Cervical Cancer Action

Strengthening Maternal Immunisation to Improve the Health of Mothers and Infants

Innovative approaches to maternal immunization have the potential to decrease serious morbidity and mortality not only in the mother, but also in the baby who is not yet able to immunologically respond to most vaccines. This article, published in …

Author: Abramson JS, Mason E

Publication date: 2016

Streptococcus pneumoniae – A Review of Carriage, Infection, Serotype Replacement and Vaccination

This article, published in Paediatric Respiratory Reviews, provides an overview on pneumococcal carriage and risk factors for invasive pneumococcal disease, the rise of non-vaccine serotypes in the era of immunization with 7-valent pneumocccal …

Author: Mehr S, Wood N

Publication date: 2012

Streptococcus pneumoniae Comparative System

This website contains data from a PATH-sponsored study on sequencing the genomes of five geographically diverse Streptococcus pneumoniae isolates. The sequencing was performed by The Institute for Genome Research (TIGR, now known as the J. Craig …

Author: The Institute for Genomic Research

Publication date: 2008

Structural Basis for Antibody Recognition of the NANP Repeats in Plasmodium falciparum Circumsporozoite Protein

This article, published in Proceedings of the National Academy of Sciences, analyzes how human antibodies recognize the immunodominant N-acetylneuraminic acid phosphatase (NANP) repeats within the malarial parasite surface protein circumsporozite …

Author: Oyen D, Torres JL, Wille-Reece U, et al.

Publication date: 2017

Structural Basis for Immunization With Postfusion Respiratory Syncytial Virus Fusion F Glycoprotein (RSV F) to Elicit High Neutralizing Antibody Titers

Respiratory syncytial virus (RSV) vaccine candidates based on a chief RSV neutralization antigen, the fusion (F) glycoprotein, have foundered due to problems with stability, purity, reproducibility, and potency. The authors of this article, …

Author: Swanson KA, Settembre EC, Shaw CA, et al.

Publication date: 2011

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

This article, published in Science, describes research to characterize the respiratory syncytial virus (RSV) fusion glycoprotein prefusion conformation, which is the target of most RSV-neturalizing activity in human sera. ABSTRACT ONLY: (Learn how …

Author: McLellan JS, Chen M, Leung S, et al

Publication date: 2013

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

This article, published in Science, describes research to engineer a respiratory synctial virus (RSV) viral antigen that focuses on antigenic site ø, a metastable site specific to the prefusion state of the RSV fusion glycoprotein. ABSTRACT ONLY. …

Author: McLellan JS, Chen M, Joyce MG, et al.

Publication date: 2013

A Study of Deafness in West Africa

This article, published in the International Journal of Pediatric Otorhinolaryngology, assessed profoundly deaf children from Nigeria in an attempt to identify the causes of deafness in this part of West Africa. The study found that measles, …

Author: Holborow C, Martinson F, Anger N

Publication date: 1982

A Study of Deafness in West Africa: The Gambian Hearing Health Project

This article, published in the International Journal of Pediatric Otorhinolaryngology, reviews data collected from several studies conducted in The Gambia to discover the incidence and causes of severe to profound hearing loss. The data shows that …

Author: McPherson B, Holborow CA

Publication date: 1985

A Study of Different Buffers to Maximize Viability of an Oral Shigella Vaccine

Live, oral vaccines against bacterial causes of diarrhea have to be formulated and administered in a way that protects them from the harsh acidic gastric environment. However, little work has been done to evaluate the volume of buffer needed to …

Author: Chandrasekaran L, Lal M, Van De Verg LL, Venkatesan MM

Publication date: 2015

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community

This article, published in Clinical Infectious Diseases, reports on a series of three short-term surveillance studies that examined the epidemiological impact of human papillomavirus (HPV) vaccine introduction over time. Specifically, the authors …

Author: Kahn JA, Widdice LE, Ding L, et al.

Publication date: 2016

Subunit Influenza Vaccines Produced From Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity

This study, published in the Journal of Infectious Diseases, assessed the safety, reactogenicity, and immunogenicity of an injectable cell culture-derived influenza vaccine, compared with those of an injectable egg-based trivalent inactivated …

Author: Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ

Publication date: 2009

Summary of Vaccine Stability Data

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format in both …

Author: PATH, Working in Tandem Ltd.

Publication date: 2012

Page 54 of 61